In late active MS lesions, PGC-1α (Figure 2D), Prx3 (Figure 2E) and Trx2 (Figure 2F) predominantly localized to astrocytes and to a much lesser extent to oligodendrocytes (2G-I). The gene discussed is TXN2; the disease is myeloid sarcoma.